JAK Research, Shiseido Research: Weekly Thoughts 1/12/16
Hello Everybody, Welcome to another edition of Weekly Thoughts. This weeks’s round-up includes new tidbits from Angela Christiano, Brian Urlacher’s hair transplant, Shiseido’s plethora of reseachers,...
View ArticleShiseido is Officially Cleared to Start RCH-01 Trial
Replicel’s hair growth therapy, RCH-01, has officially received approval by Japanese regulatory authorities to be used in a clinical trial that is now launching. We did hear some rumblings recently...
View ArticleAnti-Aging Peptide, Replicel Check-In: Weekly Thoughts 4/7/17
Hello Everyone, It is good to be back for another Weekly Thoughts. This edition is headlined by an anti-aging technology from The Netherlands that has shown interesting regenerative effects on mice. I...
View Article2018: Will It Bring A New Hair Cure?
A Happy New Year to all of you from Follicle Thought. I’ve always enjoyed doing the year ahead preview posts and this one is no exception. A new year does bring us new opportunities and should be a …...
View ArticleHair Cure April 2018: Replicel Check-In
As one of the top two hair growth treatments projected to reach the market in 2018, Replicel’s RCH-01 has a lot of people’s attention these days. When it was announced that the global cosmetic company...
View ArticleUpdate: Shiseido Talk
Follicle Thought has received a brief update to share regarding the progress of the highly anticipated company Shiseido. On July 4th I sent a tweet to Replicel CEO Lee Buckler asking him when he...
View ArticleShiseido Regulatory Path Update
After I shared an update about a potential announcement time frame for Shiseido a few weeks ago, I read a few queries from readers who wondered if a Shiseido market release would be available to...
View ArticleReplicel Newsletter March 2019
Replicel has shared a newsletter today, March 5, 2019, addressing several facets of the company’s progress and product development. The big question for many people lately has been an update on...
View ArticleReplicel Planning New Hair Loss Study In Europe
Yesterday, Replicel released a May 2019 Update which mentioned a new study using its dermal injector device to treat hair loss. The end of the press release states: “Over the next 18 months you should...
View ArticleShiseido Releases RCH-01 Trial Results 2020
Shiseido Plans To Pursue RCH-01 – Update 3/12/20 Directly from Shiseido’s “New Research” webpage regarding the RCH-01 therapy: “Safety level and improvement effects were confirmed in a clinical study...
View Article
